Suppr超能文献

抗精神病药物和锂盐在躁狂症中的应用。

Use of antipsychotic drugs and lithium in mania.

作者信息

Cookson J

机构信息

Royal London Hospital, London, UK.

出版信息

Br J Psychiatry Suppl. 2001 Jun;41:s148-56.

Abstract

BACKGROUND

Studies highlighting the difficulties associated with lithium suggest that the role of antipsychotic drugs and mood stabilizers in bipolar disorder should be reconsidered.

AIMS

To review the efficacy and mode of action of antipsychotic drugs in mania, and to consider the differences between official guidelines and routine clinical practice in the use of these agents for mania.

METHOD

Review of research, guideline- and practice-based literature.

RESULTS

Guidelines recommend lithium or valproate as first-line treatments for mania, and antipsychotic agents only as 'adjuncts' for agitation, dangerous behaviour or psychosis. However, in routine practice, antipsychotic drugs are often prescribed. The effectiveness of these agents in mania has been established by several studies; newer atypical compounds demonstrate antimanic efficacy with a reduced incidence of neurological side-effects.

CONCLUSION

Antipsychotic drugs are important in the treatment of bipolar disorder and mania. Future studies should evaluate the long-term efficacy and safety of newer atypical antipsychotic agents, and the place of anticonvulsants in combination with antipsychotics in bipolar disorder.

摘要

背景

强调锂盐相关困难的研究表明,抗精神病药物和心境稳定剂在双相情感障碍中的作用应重新审视。

目的

回顾抗精神病药物在躁狂发作中的疗效及作用方式,并探讨官方指南与这些药物用于躁狂发作的常规临床实践之间的差异。

方法

对基于研究、指南及实践的文献进行综述。

结果

指南推荐锂盐或丙戊酸盐作为躁狂发作的一线治疗药物,抗精神病药物仅作为激越、危险行为或精神病性症状的“辅助”用药。然而,在常规临床实践中,抗精神病药物常被处方使用。多项研究已证实这些药物在躁狂发作中的有效性;新型非典型化合物显示出抗躁狂疗效,且神经副作用发生率降低。

结论

抗精神病药物在双相情感障碍和躁狂发作的治疗中很重要。未来研究应评估新型非典型抗精神病药物的长期疗效和安全性,以及抗惊厥药物与抗精神病药物联合用于双相情感障碍的地位。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验